(Press-News.org) Blood fat-lowering statins could slow the progression of Alzheimer's disease, at least for some patients. This is the result of a new study led by Karolinska Institutet published in Alzheimer Research and Therapy. But the researchers are cautious in their interpretations and see the results as a first step in a research journey that may eventually provide the answer.
A new study shows that people with Alzheimer's dementia deteriorated more slowly in their cognitive functions if they were also treated with a lipid-lowering statin, compared to those who were not treated. However, the study is an observational study where the researchers have compared data on the patients from a registry and therefore cannot answer whether there really is a causal relationship. Thus, the researchers are cautious in their interpretations.
“People with Alzheimer's dementia treated with statins had better cognitive development over time. However, the results of the study do not mean that we now have evidence that people with dementia should be treated with statins. But on the other hand, we can't see any support for not doing so. So, if a person needs statins for high blood lipids, a dementia diagnosis should not stop the treatment," says Sara Garcia-Ptacek, docent of neuroscience and assistant professor at the Department of Neurobiology, Care Sciences and Society, and research leader of the current study.
The reason she emphasizes safety is that statins were initially suspected of causing confusion in patients with dementia. There has therefore been some resistance to prescribing statins to these patients.
The study included data from more than 15 500 patients with dementia who also had an indication for lipid-lowering treatment. Almost 11 000 of them were treated with statins. In general, the patients who were treated with statins had slightly higher values in the cognitive tests carried out, even though they were more likely to have diagnoses such as high blood pressure, cardiovascular disease and diabetes, all of which are risk factors for dementia.
Sara Garcia-Ptacek explains that the research team started with a hypothesis that statins could slow the progression of dementia and cast a fairly wide net to see if they could find evidence of this.
“The basic idea of this study was to pave the way for a more precise cohort study that could eventually lead to a clinical intervention study, which is what is needed to prove a causal link between statins and cognition,” says Sara Garcia-Ptacek.
The idea that statins could affect the risk or progression of dementia is not new. There are even some clinical studies done, but they have all been negative.
"We believe that only certain patients with Alzheimer's dementia may benefit from statins and that previous clinical trials have been too small to show any significant differences. "Our idea is to try to crystallize which patient groups benefit the most and why, before embarking on clinical trials," says Sara Garcia-Ptacek.
The research was funded by Region Stockholm, the Swedish Research Council and the Dementia and Margareta af Ugglas Foundation.
Publication: "Statins and cognitive decline in patients with Alzheimer's and mixed dementia: A longitudinal registry-based cohort study" Bojana Petek, Henrike Häbel, Hong Xu, Marta Villa-Lopez, Irena Kalar, Minh Tuan Hoang, Silvia Maioli, Joana B. Pereira, Shayan Mostafaei, Bengt Winblad, Milica Gregoric Kramberger, Maria Eriksdotter, Sara Garcia-Ptacek. Alzheimer Research and Therapy, online December 20, 2023, doi: 10.1186/s13195-023-01360-0
END
Finding that statins could slow dementia stimulates further research
2023-12-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Potentially harmful ‘trip-killers’ to cut short ‘bad’ drug trips, emerging concern, warn doctors
2023-12-20
The use of potentially harmful ‘trip-killers’ to cut short ‘bad drug trips’ after taking psychedelics, such as LSD or magic mushrooms, is an emerging concern, warn doctors in a research letter, published online in Emergency Medicine Journal.
Their analysis of relevant threads on the social media platform Reddit, shows that drugs such as benzodiazepines (sedatives) and antipsychotics are the options most frequently recommended, but warnings about their potential side effects are rarely included, they highlight.
The intensity of a psychedelic drug trip can cause distress, agitation, ...
3 potentially unique acoustic features of healing music that transcend genre identified
2023-12-20
There are three potentially unique acoustic features of healing music that transcend musical genres, suggests research published in the open access journal General Psychiatry.
The findings might help to personalise playlists for patients, using artificial intelligence to analyse individual physiological and psychological responses, and help to evaluate the effectiveness of existing music therapies, suggest the researchers.
Despite evidence of the therapeutic effects of music for mental health issues, such as anxiety, depression, and post traumatic stress disorder, there’s no consensus on what defines healing ...
Diabetes drug may significantly lower women’s risk of substantial weight gain after giving up smoking
2023-12-20
The diabetes drug dulaglutide (Trulicity) may significantly lower a woman’s risk of substantial weight gain after she has given up smoking, finds a secondary analysis of clinical trial data, published in the open access journal BMJ Nutrition Prevention & Health.
Women seem to be 5 times as likely as men to put on a lot of weight after they’ve stubbed out what they intend to be their last cigarette, the analysis suggests.
Women seem to have higher smoking relapse rates than men. And it’s been suggested that one of the possible explanations for this is that they may be more concerned about ...
Antimicrobial resistance leads to more deaths and illnesses in the WHO African region than anywhere else
2023-12-20
SEATTLE, Wash., Dec. 19, 2023 ‑‑ Over 1.05 million deaths were associated with antimicrobial resistance (AMR) and 250,000 deaths were attributable to AMR in the WHO African region, posing an unprecedented health threat. That’s according to a new study published in The Lancet Global Health today.
The number of deaths linked to AMR in the WHO African region is higher than those caused by both HIV/AIDS (639,554) and malaria (594,348), marking a pivotal shift in the health challenges facing the region. Despite the relatively low prevalence of resistance, the WHO African region had the highest burden of AMR mortality, which ...
Groundbreaking discovery at Museums Victoria Research Institute rewrites our understanding of whale evolution
2023-12-20
Groundbreaking new research from the Museums Victoria Research Institute has turned upside down our previous understanding of the evolution of the largest animals ever––baleen whales.
Palaeontologists Dr James Rule (Monash University and Natural History Museum, London) and Dr Erich Fitzgerald (Museums Victoria Research Institute) have co-authored the open access paper ‘Giant baleen whales emerged from a cold southern cradle’, published today in the prestigious journal Proceedings of the Royal Society B.
Until now, it was believed that the beginning of the Ice Age in the ...
Scientists provide recipe to halve pollution from food production
2023-12-20
A major report for the United Nations has put forward solutions to halve nitrogen pollution from agriculture and the food system in Europe, including reducing meat and dairy consumption, fertiliser use and food waste.
Nitrogen, which is vital for plant growth, is present in animal excreta and synthetic fertilisers that are applied to land to boost crop production. But excessive and inefficient use of this nutrient means up to 80% of it leaks into the environment, mostly in various polluting forms of nitrogen: ammonia and nitrogen oxides, which are harmful air pollutants; ...
Huntsman Cancer Institute investigator receives award for metastatic breast cancer research
2023-12-20
Alana Welm, Ph.D., senior director of basic science at Huntsman Cancer Institute and professor of oncological sciences at the University of Utah (the U), received the 2023 American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer Research.
“Dr. Welm is an exceptionally talented and internationally-recognized scientist, applying her discoveries to the development of improved breast cancer therapies,” says Neli Ulrich, Ph.D., MS, chief scientific officer and executive director of the comprehensive cancer center at Huntsman Cancer Institute and professor of population health sciences at the U. “She has a highly productive research ...
Endometrial cancer: New insights into a deadly disparity
2023-12-20
The numbers are stark and deeply troubling.
Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than 66,000 cases.
Deaths from the disease have also grown alarmingly in the same period, from less than 3,000 to more than 13,000 in the U.S. every year. And the trend line is not getting better.
“Endometrial cancer has been increasing at unprecedented levels over the past five years,” ...
Sanford Burnham Prebys continues unprecedented recruitment of early-career scientists
2023-12-20
Continuing its rapid and dramatic recruitment of emerging, top-tier researchers, Sanford Burnham Prebys has hired two more highly regarded early-career scientists: Angela Liou, M.D., a specialist in pediatric oncology and hematology; and Xueqin Sherine Sun, Ph.D., a cancer biologist and genome engineer.
“With Drs. Liou and Sun, we have now hired eight superb young scientists and physicians in less than a year, an achievement that reflects the extraordinary challenges in biomedical research today and our ambitious plans ...
Research offers a reason why diversity in plant species causes higher farming yield, solving 'a bit of a mystery'
2023-12-20
LAWRENCE — A study appearing in Nature Communications based on field and greenhouse experiments at the University of Kansas shows how a boost in agricultural yield comes from planting diverse crops rather than just one plant species: Soil pathogens harmful to plants have a harder time thriving.
“It’s commonly observed that diverse plant communities can be more productive and stable over time,” said corresponding author James Bever, senior scientist with the Kansas Biological Survey & Center for Ecological Research and Foundation Distinguished Professor of Ecology & Evolutionary Biology at KU. ...